Clinical Trials Directory

Trials / Sponsors / Les Laboratoires des Médicaments Stériles

Les Laboratoires des Médicaments Stériles

Industry · 13 registered clinical trials3 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingComparison of the Efficacy and Safety of GLARGEN® Versus NPH Insulin in Diabetic Tunisian Patients.
Diabetes Mellitus
Phase 42025-07-01
Enrolling By InvitationApixaban Versus Rivaroxaban in Non Valvular Atrial Fibrillation
Non Valvular Atrial Fibrillation
Phase 42024-12-01
RecruitingTunisian Registry of Trans Catheter Aortic Valve Implantation
Tunisian Patients Already Implanted With a TAVI
2023-09-23
CompletedEpidemiologic Register on Diabetes and COVID-19 in Tunisia
COVID-19 Disease
2022-03-23
UnknownThe Impact of Telemonitoring in the Management of Hypertension
Health Services Administration, Telemedicine, Hypertension
N/A2020-07-04
UnknownImpact of A Nutritional Supplements' Combination (FERTILIS) on Male Infertility
Infertility, Male, Subfertility, Male
N/A2020-02-17
CompletedOptimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradi
Helicobacter Pylori
Phase 42019-01-29
CompletedComparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Loveno
Gastrointestinal Neoplasms, Thromboembolic Event
Phase 42015-10-01
CompletedEnoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
Placental Insufficiency, Enoxaparin
Phase 42013-10-23
CompletedComparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
Acute Coronary Syndrome, Factor X
Phase 42012-07-01
CompletedEffect of Platelet Inhibition According to Clopidogrel Dose in Patients With Body Mass Index ≥ 27
Cardiovascular Disease, Overweight
Phase 42011-12-01
CompletedEcho-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxapar
Deep Vein Thrombosis, Venous Thrombosis, Adverse Effect of Anticoagulants
Phase 42011-03-01
CompletedClinical Assessment of Pidogrel® Versus Plavix® (CAPP)
Coronary Disease
Phase 42010-04-01